ASP Isotopes Inc. Files 8-K Report
Ticker: ASPI · Form: 8-K · Filed: Sep 2, 2025 · CIK: 1921865
Sentiment: neutral
Topics: disclosure, filing
TL;DR
ASP Isotopes filed an 8-K, check for updates.
AI Summary
On September 2, 2025, ASP Isotopes Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events beyond the filing itself were detailed in the provided text.
Why It Matters
This filing indicates that ASP Isotopes Inc. has submitted required disclosures to the SEC, which may contain important updates for investors regarding financial status or other material information.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure and does not contain information indicating immediate risk.
Key Players & Entities
- ASP Isotopes Inc. (company) — Registrant
- September 2, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41555 (filing_id) — Commission File Number
- 87-2618235 (tax_id) — IRS Employer Identification No.
- 601 Pennsylvania Avenue NW, South Building, Suite 900 Washington, DC 20004 (address) — Principal executive offices
- (202) 756-2245 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by ASP Isotopes Inc.?
The filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported was on September 2, 2025.
In which U.S. state is ASP Isotopes Inc. incorporated?
ASP Isotopes Inc. is incorporated in Delaware.
What is the Commission File Number for ASP Isotopes Inc.?
The Commission File Number is 001-41555.
What is the business address listed for ASP Isotopes Inc.?
The business address is 601 Pennsylvania Avenue NW, South Building, Suite 900, Washington, DC 20004.
Filing Stats: 519 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2025-09-02 09:34:17
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 ASPI The Nasdaq Stock Market LLC
Filing Documents
- aspi_8k.htm (8-K) — 26KB
- aspi_ex991.htm (EX-99.1) — 48KB
- aspi_ex991img3.jpg (GRAPHIC) — 3KB
- aspi_ex991img5.jpg (GRAPHIC) — 2KB
- 0001477932-25-006452.txt ( ) — 215KB
- aspi-20250902.xsd (EX-101.SCH) — 5KB
- aspi-20250902_lab.xml (EX-101.LAB) — 15KB
- aspi-20250902_cal.xml (EX-101.CAL) — 1KB
- aspi-20250902_pre.xml (EX-101.PRE) — 10KB
- aspi-20250902_def.xml (EX-101.DEF) — 2KB
- aspi_8k_htm.xml (XML) — 4KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On September 2, 2025, ASP Isotopes Inc. (the "Company") issued a letter to shareholders. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 ASP Isotopes Inc. Letter to Shareholders, dated September 2, 2025. 104 Cover Page Interactive Date File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASP ISOTOPES INC. Date: September 2, 2025 By: /s/ Donald G. Ainscow Name: Donald G. Ainscow Title: Executive Vice President, General Counsel and Secretary 3